Our Mission

TomoTissue is at the forefront of revolutionising biomedical research and (pre)clinical diagnostics through its pioneering X-ray-based 3D histology services.

By leveraging our extensive expertise in microfocus X-ray computed tomography (XCT) and contrast-enhanced XCT (CECT) imaging,

we provide a non-destructive and highly detailed examination of biomaterials and biological tissues, a technique we refer to as X-ray-based 3D histology.

Unlike conventional contrast-enhancing staining agents (CESAs), our in-house synthesised agents demonstrate exceptional preservation of tissue integrity.

Our mission is to deliver high-quality 3D imaging data and data analysis, catering to the diverse needs of commercial and academic research institutes, (pre)clinical pathology laboratories, as well as pharmaceutical and biotechnology companies.